REPORTS

Let’s Pullulate and Expand Your Business

Pet Vaccine Market - Global Professional Analysis and Forecast to 2026

Jan 27, 2020  |  200 PAGES  |  REPORT CODE: CMM263649
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Pet Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.2% during the forecast period.

This report presents the market size and development trends by detailing the Pet Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pet Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pet Vaccine industry and will help you to build a panoramic view of the industrial development.

Pet Vaccine Market, By Type:

  • Attenuated Live Vaccines

  • Conjugate Vaccines

  • Inactivated Vaccines

  • Subunit Vaccines

  • Toxoid Vaccines

  • DNA Vaccines

  • Recombinant Vaccines

Pet Vaccine Market, By Application:

  • Canine

  • Avian

  • Feline

Some of the leading players are as follows:

  • Merial (Sanofi)

  • Ceva

  • Merck Animal Health

  • Boehringer Ingelheim

  • Virbac

  • Zoetis (Pfizer)

  • Eli Lilly

  • Bayer Healthcare

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Pet Vaccine Market: Technology Type Analysis

  • 4.1 Pet Vaccine Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Pet Vaccine Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Attenuated Live Vaccines

    • 4.3.2 Conjugate Vaccines

    • 4.3.3 Inactivated Vaccines

    • 4.3.4 Subunit Vaccines

    • 4.3.5 Toxoid Vaccines

    • 4.3.6 DNA Vaccines

    • 4.3.7 Recombinant Vaccines

5 Pet Vaccine Market: Product Analysis

  • 5.1 Pet Vaccine Product Market Share Analysis, 2018 & 2026

  • 5.2 Pet Vaccine Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Pet Vaccine Market: Application Analysis

  • 6.1 Pet Vaccine Application Market Share Analysis, 2018 & 2026

  • 6.2 Pet Vaccine Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Canine

    • 6.3.2 Avian

    • 6.3.3 Feline

7 Pet Vaccine Market: Regional Analysis

  • 7.1 Pet Vaccine Regional Market Share Analysis, 2018 & 2026

  • 7.2 Pet Vaccine Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Merial (Sanofi)

    • 9.1.1 Merial (Sanofi) Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Ceva

    • 9.2.1 Ceva Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Merck Animal Health

    • 9.3.1 Merck Animal Health Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Boehringer Ingelheim

    • 9.4.1 Boehringer Ingelheim Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Virbac

    • 9.5.1 Virbac Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Zoetis (Pfizer)

    • 9.6.1 Zoetis (Pfizer) Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Eli Lilly

    • 9.7.1 Eli Lilly Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Bayer Healthcare

    • 9.8.1 Bayer Healthcare Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

 

The List of Tables and Figures (Totals 62 Figures and 142 Tables)

  • Figure Attenuated Live Vaccines Pet Vaccine market, 2015 - 2026 (USD Million)

  • Figure Conjugate Vaccines Pet Vaccine market, 2015 - 2026 (USD Million)

  • Figure Inactivated Vaccines Pet Vaccine market, 2015 - 2026 (USD Million)

  • Figure Subunit Vaccines Pet Vaccine market, 2015 - 2026 (USD Million)

  • Figure Toxoid Vaccines Pet Vaccine market, 2015 - 2026 (USD Million)

  • Figure DNA Vaccines Pet Vaccine market, 2015 - 2026 (USD Million)

  • Figure Recombinant Vaccines Pet Vaccine market, 2015 - 2026 (USD Million)

  • Figure Canine market, 2015 - 2026 (USD Million)

  • Figure Avian market, 2015 - 2026 (USD Million)

  • Figure Feline market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Pet Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table North America Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table North America Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table North America Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Canada Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Canada Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Europe Pet Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Europe Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Europe Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Europe Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Germany Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Germany Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table France Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table France Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Italy Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Italy Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Spain Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Spain Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pet Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table China Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table China Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Japan Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Japan Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table India Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table India Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Pet Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table MEA Pet Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table MEA Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table MEA Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table MEA Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Pet Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Pet Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Pet Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Merial (Sanofi) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ceva Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Animal Health Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Virbac Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zoetis (Pfizer) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Healthcare Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top